-

Fast Identification of Omicron Spread Through Wastewater Monitoring in Denmark, and Strong Cooperation Between Eurofins and Statens Serum Institut (SSI, Danish Health Authorities) Has Enabled Prompt Action Against the Pandemic

LUXEMBOURG--(BUSINESS WIRE)--For a number of months now, Eurofins Scientific (Paris:ERF) has been monitoring wastewater in Denmark for the presence of SARS-CoV-2, through the regular (3 times per week) sampling of around 200 wastewater treatment plants across the country. Wastewater is an effective mirror of society, and wastewater testing is acknowledged as a way to monitor the virus’ spread and to detect new variants early, often before the first clinical cases are known.

On 1st December 2021, as part of the national surveillance programme, Eurofins received the regularly planned wastewater samples to be tested for the presence of SARS-CoV-2. In parallel, 80 samples were also tested through the Eurofins VIRType™ SARS-CoV-2 (L452R) and VIRType™ SARS-CoV-2 (K417N) kits, to potentially identify the presence of the Delta and Omicron variants, through rapid detection of single point K417N and L452R mutations respectively.

On 2nd December, 3 of these wastewater samples tested positive for the mutation K417N, indicating the likely presence of Omicron.

SSI was immediately informed, and the 3 positive samples shipped to them for confirmation through NGS sequencing. On 3rd December, the presence of Omicron was confirmed, providing the Danish authorities with very early warning of the presence of the new variant and allowing them to take the necessary measures rapidly. The first known human case of Omicron in Denmark was found on 27th November.

Scientific innovation, testing capacity and very close cooperation between Eurofins and the Danish authorities has enabled a fast response and targeted management of the pandemic.

Eurofins continues to innovate and make such services available to health authorities in many countries in Europe and beyond.

Notes to Editors:

For more information, please visit www.eurofins.com

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With 55,000 staff across a network of 900 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Investor Relations
Eurofins Scientific SE
Jesper Gamst
Phone: +32 2 766 1620
E-mail: ir@eurofins.com

Eurofins Scientific

BOURSE:ERF

Release Versions

Contacts

Investor Relations
Eurofins Scientific SE
Jesper Gamst
Phone: +32 2 766 1620
E-mail: ir@eurofins.com

More News From Eurofins Scientific

Eurofins: Purchases of Own Shares From April 22nd to April 25th 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS 529900JEHFM47DYY3S57 22/03/2025 FR0014000MR3 88,000 49.0621 XPAR EUROFINS 529900JEHFM47DYY3S57 22/03/2025 FR0014000MR3 54,000 49.0614 CEUX EUROFINS 529900JEHFM47DYY3S57 22/03/2025 FR0014000MR3 4,000...

Eurofins launches sixth buy-back programme of its own shares

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Eurofins Scientific SE (the “Company”) (EUFI.PA) announces its intention to launch a new buy-back programme of its own shares (ISIN FR0014000MR3) for a maximum amount representing up to 4.5% of its share capital. This sixth programme follows the first programme that took place between 3 October 2022 and 8 August 2023, the second programme that took place between 25 October 2023 and 30 August 2024, the third programme that took...

Eurofins Delivers 6.9% Revenue Growth in Q1 2025 and Continues to Make Progress on the Build Out of Its Best-in-Class, Fully Digital Global Laboratory Network

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: The Eurofins (Paris:ERF) network of companies achieved solid growth in most business lines in Q1 2025: Reported revenues in Q1 2025 totalled €1,767m, an increase of 6.9% vs Q1 2024, driven by organic growth13,A and acquisitions, despite a negative public working day impact. Organic revenue growth13,A was 3.9%, which includes an adjustment for public working days of 1.2%: In Europe, organic growth13,A of 3.9% (2.9% excluding adjustment for public wor...
Back to Newsroom